Literature DB >> 18396195

Current neurosurgical management of brain metastases.

David W Andrews1.   

Abstract

Brain metastases occur in a third of patients diagnosed with cancer; without any intervention, the prognosis is quite poor with a median survival of 1 month. Because of the constraints of the blood-brain barrier, chemotherapy is not effective and treatment options include surgery, whole brain radiation, or stereotactic radiation. This chapter is devoted to a review of the current management options for treatment of brain metastases.

Entities:  

Mesh：

Year:  2008        PMID： 18396195     DOI： 10.1053/j.seminoncol.2007.12.003

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


  5 in total

1.  Vorinostat as a radiosensitizer for brain metastasis: a phase I clinical trial.

Authors:  Wenyin Shi; Yaacov Richard Lawrence; Hak Choy; Maria Werner-Wasik; David W Andrews; James J Evans; Kevin D Judy; Christopher J Farrell; Yaron Moshel; Adam C Berger; Voichita Bar-Ad; Adam P Dicker
Journal:  J Neurooncol       Date:  2014-04-13       Impact factor: 4.130

2.  Plan Quality and Treatment Efficiency for Radiosurgery to Multiple Brain Metastases: Non-Coplanar RapidArc vs. Gamma Knife.

Authors:  Haisong Liu; David W Andrews; James J Evans; Maria Werner-Wasik; Yan Yu; Adam Paul Dicker; Wenyin Shi
Journal:  Front Oncol       Date:  2016-02-11       Impact factor: 6.244

Review 3.  Current concepts in stereotactic radiosurgery - a neurosurgical and radiooncological point of view.

Authors:  Jan Vesper; B Bölke; C Wille; P A Gerber; C Matuschek; M Peiper; H J Steiger; W Budach; G Lammering
Journal:  Eur J Med Res       Date:  2009-03-17       Impact factor: 2.175

4.  Three-fraction CyberKnife radiotherapy for brain metastases in critical areas: referring to the risk evaluating radiation necrosis and the surrounding brain volumes circumscribed with a single dose equivalence of 14 Gy (V14).

Authors:  Hiroshi K Inoue; Ken-Ichi Seto; Akihiko Nozaki; Kota Torikai; Yoshiyuki Suzuki; Jun-Ichi Saitoh; Shin-Ei Noda; Takashi Nakano
Journal:  J Radiat Res       Date:  2013-02-11       Impact factor: 2.724

5.  Five-fraction CyberKnife radiotherapy for large brain metastases in critical areas: impact on the surrounding brain volumes circumscribed with a single dose equivalent of 14 Gy (V14) to avoid radiation necrosis.

Authors:  Hiroshi K Inoue; Hiro Sato; Ken-ichi Seto; Kota Torikai; Yoshiyuki Suzuki; Jun-ichi Saitoh; Shin-ei Noda; Takashi Nakano
Journal:  J Radiat Res       Date:  2013-11-01       Impact factor: 2.724
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.